Where do artificial intelligence and robotics fit into discoveries? In this session of the Newton Series, Steve Finkbeiner, MD, PhD, explains how these tools contribute to his lab’s work in understanding the fundamentals of brain cells, which he hopes will lead to discoveries in memory diseases like Alzheimer’s or Parkinson’s.
The Newton Webinar Series is inspired by the story of Isaac Newton’s extraordinary intellectual output while in quarantine during the Great London Plague of 1665, and offers an alternative to all the news related to COVID-19. Each week, we feature a conversation with Gladstone’s scientists and explore their moonshot ideas, how they approach their work, and what they think medicine may look like 10, 20, and 50 years from now.
Support Discovery Science
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Meet Gladstone: Christina Buselli
Article
November 14, 2023
Meet Gladstone: Christina Buselli
Research Associate Christina Buselli describes her work in the Finkbeiner lab, her path to science, and the questions she wishes she could ask her grandfather
Profile Finkbeiner LabWhen Two Disruptive Technologies Converge
Article
September 27, 2023
When Two Disruptive Technologies Converge
How gene editing and stem cells are working in tandem at Gladstone Institutes to change science and medicine
Deep Dive Stem Cells/iPSCs CRISPR/Gene Editing Srivastava Lab Yamanaka Lab Doudna Lab Conklin Lab Marson Lab Huang Lab Ott LabWorld’s Largest Public ALS Data Portal Launched
Article
April 13, 2021
World’s Largest Public ALS Data Portal Launched
Steve Finkbeiner is leading key components of this unprecedented resource to boost ALS research.
Gladstone Experts ALS Center for Systems and Therapeutics Finkbeiner Lab AI Robotic Microscopy Stem Cells/iPSCs